Current articles and info about your health

Friday, 29th August 2008

   home     about     authors     news     books     xml feed     sitemap     privacy     contact us

There are 7 users online

add to favorites
 make home page


Addiction Issues
 Aging
 Allergies & Sinuses
 Alternative Medicine
 Beauty & Health
 Books & Reading
 Common Illnesses
 Community Service
 Diabetic Health
 Dieting
 Diseases
 Environmental Health
 Exercise and Fitness
 Health Education
 Health Industry
 Health Insurance
 Health Legal Issues
 Health Technology
 Healthcare Services
 Healthy Eating
 Medical Equipment & Products
 Men's Health
 Mental and Emotional Health
 Muscle & Back Pain
 Nutrition and Supplements
 Pediatrics
 Pet Health
 Physical Therapy & Massage
 Prevention Health
 Vision Health
 Weight Management
 Women's Health

Our Newsletter

Sign up for our free
Health-Informant.com Ezine
Get all the latest Health news delivered right to your mailbox.

First Name:

Your Email:



We will never rent, share or sell your name to anyone else... ever! We respect your privacy!
  Other Resources


For other sources of health news, tips, and information, visit our resources page

 

  Submit an Article


Would you like to have your article posted? Click Here
 

 
 

Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla
Added: 05/12/2004
 Type: Summary
 Viewed: 789 time(s)
 [ Not Rated Yet ]
How would you rate this article:    Bad Good   Go » 
Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla

 Baxa Corporation is sponsoring a dinner symposium for pharmacy and nursing professionals to discuss the findings in a recent study from the American Journal of Health-System Pharmacy (AJHP). The symposium will be held Tuesday, May 18th at the W hotel in Los Angeles, CA.

The symposium presents the findings from the study, entitled "Using a Closed-System Protective Device to Reduce Personnel Exposure to Antineoplastic Agents," on biological uptake of cyclophosphamide and ifosfamide in infusion center pharmacy and nursing staff in a newly built cancer center at the University of Utah. The presenter, Jim Jorgenson, RPh, is Director of Pharmacy for the Huntsman Cancer Institute, where the study took place.

Study data documented that standard worker precautions and safe handling guidelines were not effective in preventing environmental exposure and subsequent uptake of the chemotherapy drugs in the healthcare workers tested. These findings have been supported in a NIOSH Alert entitled, "Preventing Occupational Exposures to Antineoplastic and other Hazardous Drugs in Healthcare Settings" published last month to the Centers for Disease Control (CDC) Web site.

The clinicians who authored the study demonstrated biological uptake of the two drugs tested through urine studies with pharmacy and nursing personnel. Additionally, wipe samples of selected facility and equipment surfaces yielded positive results for all samples.

Following these baseline tests, the PhaSeal closed-loop drug containment system was implemented in the chemotherapy infusion center, while workers continued the preparation and administration safeguards already in use. Six months following the adoption of the PhaSeal System, the presence of the two drugs originally detected in urine samples from center personnel had been reduced to undetectable levels. The study also showed that drug contamination initially detected on infusion center surfaces was significantly reduced following implementation of the PhaSeal System.

The complimentary symposium will be held Tuesday, May 18th at the W hotel of Los Angeles, CA, beginning at 5:30 PM. Participants are eligible for one credit hour of Continuing Education (CEU).
Article Pages:  1  



  Article Comments   Add Comment | View All (0)
    There are currently no comments for this article.


All content © 2008 Webmaster, Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla :: Health-Informant.com.